Literature DB >> 17989623

Stent-graft treatment of trauma to the supra-aortic arteries. A review.

C J Schönholz1, R Uflacker, M A De Gregorio, J C Parodi.   

Abstract

Trauma to the carotid, subclavian, vertebral, or innominate arteries may be blunt or penetrating. Some injuries, such as those caused by central venous catheterization, are iatrogenic. Trauma-induced fistulas and pseudoaneurysms of the supra-aortic arteries are relatively rare, but may result in disabling neurologic symptoms or death. Traditional surgical approaches to supra-aortic artery trauma have high morbidity and mortality rates, especially in patients with multiple injuries and patients with a serious concomitant illness. The minimally invasive endovascular approach may offer an alternative that avoids the tissue damage, bleeding, infectious complications, pain and disability, long recovery time, and high financial cost associated with surgery. In the past 15 years, stent-grafts have evolved from bare-metal stents to which the operator attached autologous vein or a prosthetic material to manufactured balloon-expandable or self-expanding endoprosthetic systems. No devices designed specifically for use in the supra-aortic arteries are yet available. Nevertheless, the reported experience with stent-graft treatment of supra-aortic artery trauma is growing rapidly, although it remains limited to case reports and small series with relatively short follow-up times. Results have been very promising: complete lesion exclusion from the circulation and resolution of symptoms has been achieved in almost all cases, and few procedural complications and stent-graft stenoses and thromboses have been reported. The stent-graft approach warrants additional research on its long-term outcomes, as well as continued development of enhancements for the devices used.

Entities:  

Mesh:

Year:  2007        PMID: 17989623

Source DB:  PubMed          Journal:  J Cardiovasc Surg (Torino)        ISSN: 0021-9509            Impact factor:   1.888


  8 in total

Review 1.  Peripheral endografts for the treatment of traumatic arterial injuries.

Authors:  Konstantinos Katsanos; Tarun Sabharwal; Tom Carrell; Renato Dourado; Andreas Adam
Journal:  Emerg Radiol       Date:  2008-10-22

2.  Successful surgical treatment of right subclavian artery aneurysm with a hypoplastic left vertebral artery using temporary cerebral perfusion to prevent cerebral ischemia.

Authors:  Hiroshi Ito; Hiroshi Kurazumi; Kensuke Sakata; Yurio Koabayashi
Journal:  Ann Vasc Dis       Date:  2011-03-26

3.  Traumatic Cervical Vertebral Artery Transection Associated with a Dural Tear Leading to Subarachnoid Extravasation.

Authors:  Mark O Baerlocher; Tanya L Zakrison; Homer Tien; Richard I Aviv; Sean P Symons
Journal:  Eur J Trauma Emerg Surg       Date:  2008-07-17       Impact factor: 3.693

Review 4.  Endovascular Considerations in Traumatic Injury of the Carotid and Vertebral Arteries.

Authors:  Ananth K Vellimana; Jayson Lavie; Arindam Rano Chatterjee
Journal:  Semin Intervent Radiol       Date:  2021-04-15       Impact factor: 1.513

5.  An uncommon, life-threatening, traumatic hematoma in the neck area.

Authors:  Michalis Peroulis; Georgios D Lianos; Vasilios Nousias; Zoi Anastasiadi; Aikaterini Lianou; Christos Katsios; Miltiadis Matsagkas
Journal:  Case Rep Emerg Med       Date:  2014-11-24

6.  Hybrid treatment of an aortic pseudoaneurysm arising at the innominate artery junction secondary to superior vena cava stenting.

Authors:  Arnaud Roussel; Dominique Fabre; Elie Fadel; Claude Angel; Philippe Dartevelle
Journal:  J Vasc Surg Cases       Date:  2015-06-16

7.  Minimal invasive management of traumatic transection of the vertebral artery.

Authors:  Steve Mm de Castro; Sarah C Christiaans; Rene van den Berg; Niels Wl Schep
Journal:  Springerplus       Date:  2014-04-28

8.  Management of injuries near the innominate artery bifurcation using an accurate kissing Viabahn stent technique.

Authors:  Shuang-Long Hu; Chun-Xin Wang; Hui-Jun Lu; Ye Yuan
Journal:  J Int Med Res       Date:  2020-05       Impact factor: 1.671

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.